Quarterly report pursuant to Section 13 or 15(d)

Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.19.3
Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Series C Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 368 $ 1,711,197 $ (11,460,989) $ (9,749,424)
Balance, shares at Dec. 31, 2017 3,679,500      
Stock based compensation expense 28,054 28,054
Issuance of warrants 304,395 304,395
Net income (loss) (1,412,686) (1,412,686)
Balance at Mar. 31, 2018 $ 368 2,043,646 (12,873,675) (10,829,661)
Balance, shares at Mar. 31, 2018 3,679,500      
Balance at Dec. 31, 2017 $ 368 1,711,197 (11,460,989) (9,749,424)
Balance, shares at Dec. 31, 2017 3,679,500      
Net income (loss)         (7,137,615)
Balance at Sep. 30, 2018 $ 619 17,817,352 (23,522,471) (5,704,500)
Balance, shares at Sep. 30, 2018 6,191,373      
Balance at Mar. 31, 2018 $ 368 2,043,646 (12,873,675) (10,829,661)
Balance, shares at Mar. 31, 2018 3,679,500      
Stock based compensation expense 28,054 28,054
Issuance of warrants 263,055 263,055
Net income (loss) (2,716,255) (2,716,255)
Balance at Jun. 30, 2018 $ 368 2,334,755 (15,589,930) (13,254,807)
Balance, shares at Jun. 30, 2018 3,679,500      
Stock based compensation expense $ 1 500,933 500,934
Stock based compensation expense, shares 8,334      
Stock issued in settlement of litigation 939,538 939,538
Stock issued in settlement of litigation, shares      
Conversion of Class B convertible preferred stock $ 137 4,961,431 4,961,568
Conversion of Class B convertible preferred stock, shares   1,366,768      
Issuance of warrants to third parties for capital raise 26,843 26,843
Conversion of deferred salaries $ 14 650,086 650,100
Conversion of deferred salaries, shares 136,863      
Conversion of convertible debentures $ 172 6,267,924 6,268,096
Conversion of convertible debentures, shares 1,726,678      
Conversion of advance from officer $ 4 199,996 200,000
Conversion of advance from officer, shares 42,105      
Conversion of notes payable $ 22 782,728 782,750
Conversion of notes payable, shares 215,625      
Sale of common stock in public offering $ 267 8,013,961 8,014,228
Sale of common stock in public offering, shares 2,670,000      
Sale of common stock in over-allotment to underwriters $ 2 121,907 121,909
Sale of common stock in over-allotment to underwriters, shares 25,000      
Common stock deemed dividend (980,375) (980,375)
Common stock deemed dividend, shares      
Accretion of redeemable convertible preferred stock dividend $ (3,667,620) (3,667,620)
Accretion of redeemable convertible preferred stock dividend, shares    
Net income (loss) (23,522,471) (3,008,675)
Balance at Sep. 30, 2018 $ 619 17,817,352 (23,522,471) (5,704,500)
Balance, shares at Sep. 30, 2018 6,191,373      
Balance at Dec. 31, 2018 $ 987 20,152,107 (39,112,401) (18,959,307)
Balance, shares at Dec. 31, 2018 9,870,873      
Issuance of common stock upon exercise of Series A Warrants, net of issuance cost $ 42 2,172,638 2,172,680
Issuance of common stock upon exercise of Series A Warrants, net of issuance cost, shares 424,116      
Issuance of common stock as inducement to exercise Series A Warrants $ 51 (51)
Issuance of common stock as inducement to exercise Series A Warrants, shares 508,940      
Issuance of common stock upon exercise of Series B warrants $ 363 5,635,406 5,635,769
Issuance of common stock upon exercise of Series B warrants, shares 3,629,045      
Issuance of common stock upon exercise of Placement Agent Warrants 16,818 16,818
Issuance of common stock upon exercise of Placement Agent Warrants, shares 4,004      
Stock based compensation expense 105,642 105,642
Net income (loss) 500,213 500,213
Balance at Mar. 31, 2019 $ 1,443 28,082,560 (38,612,188) (10,528,185)
Balance, shares at Mar. 31, 2019 14,436,978      
Balance at Dec. 31, 2018 $ 987 20,152,107 (39,112,401) (18,959,307)
Balance, shares at Dec. 31, 2018 9,870,873      
Net income (loss)         (2,181,707)
Balance at Sep. 30, 2019 $ 2,800 41,463,387 (41,294,108) 172,079
Balance, shares at Sep. 30, 2019 28,000,151      
Balance at Mar. 31, 2019 $ 1,443 28,082,560 (38,612,188) (10,528,185)
Balance, shares at Mar. 31, 2019 14,436,978      
Issuance of common stock upon exercise of Series B warrants $ 876 7,732,587 7,733,463
Issuance of common stock upon exercise of Series B warrants, shares 8,749,953      
Issuance of Series C preferred stock upon exchange of Series A and Series B warrants 3,671,024 3,671,024
Issuance of Series C preferred stock upon exchange of Series A and Series B warrants, shares      
Stock based compensation expense 104,121 104,121
Net income (loss) 7,422 7,422
Balance at Jun. 30, 2019 $ 2,319 39,590,292 (38,604,766) 987,845
Balance, shares at Jun. 30, 2019 23,186,931      
Issuance of common stock upon Series C preferred (conversion) $ 100 (100)
Issuance of common stock upon Series C preferred (conversion), shares 1,000,000      
Issuance of common stock upon exercise of Series B warrants $ 381 1,214,758 1,215,139
Issuance of common stock upon exercise of Series B warrants, shares 3,813,220      
Stock based compensation expense 63,437 63,437
Warrants issued in connection with convertible notes payable 595,000 595,000
Net income (loss) (2,689,342) (2,689,342)
Balance at Sep. 30, 2019 $ 2,800 $ 41,463,387 $ (41,294,108) $ 172,079
Balance, shares at Sep. 30, 2019 28,000,151